Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
9.47
+0.20 (2.16%)
At close: Jun 25, 2026, 4:00 PM EDT
9.54
+0.07 (0.74%)
After-hours: Jun 25, 2026, 5:22 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $693.87 million as of June 25, 2026. Its market cap has increased by 136.73% in one year.
Market Cap
693.87M
Enterprise Value
535.85M
1-Year Change
136.73%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $693.87M, an increase of 212.01%. That is a compound annual growth rate of 26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 693.87M | 123.70% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 707.75M |
| Immix Biopharma | 705.49M |
| Climb Bio | 704.30M |
| Tenax Therapeutics | 696.89M |
| Aclaris Therapeutics | 687.15M |
| CytomX Therapeutics | 685.76M |
| CorMedix | 674.69M |
| Rigel Pharmaceuticals | 658.86M |